A tyrosine kinase inhibitor lenvatinib is oxidized by human cytochromes P450 and aldehyde oxidase in vitro

FEBS OPEN BIO

VÁVROVÁ, K.; INDRA, R.; POMPACH, P.; HEGER, Z.; ADAM, V.; ECKSCHLAGER, T.; KOPEČKOVÁ, K.; STIBOROVÁ, M., 2018: A tyrosine kinase inhibitor lenvatinib is oxidized by human cytochromes P450 and aldehyde oxidase in vitro. FEBS OPEN BIO 8, p. 351 - 1; FULL TEXT

CEITEC authors: